PureTech Health plc (PRTC)

R&D to Revenue

952.32%

Quarterly · Period ending:

PRTC logo

PRTC R&D to Revenue

Latest reported952.32%
PRTC Quarterly R&D/Revenue (52.73% → 952.32%)
High-resolution chart · PNG

PRTC r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

PureTech Health plc R&D to Revenue — Quarterly
Period endingR&D to Revenue
952.3197%
1,127.7423%
1,345.2188%
381.2267%
13,516.6667%
23,938.3333%
1,687.1746%
790.1945%
1,202.9441%
537.9242%
828.1357%
885.6418%
558.8837%
744.2989%
1,037.3148%
279.9062%
668.2339%
1,940.1604%
5,321.9549%
618.2429%
6,301.6461%
1,465.3159%
61.0156%
308.2255%
169.7368%
51.1653%
33.3059%
33.3059%
52.7314%
52.7314%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.